Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-24-006114
Filing Date
2024-04-29
Accepted
2024-04-29 16:15:31
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A gdnsf-20231231x10ka.htm   iXBRL 10-K/A 699863
2 EX-10.63 gdnsf-20231231xex10d63.htm EX-10.63 181936
3 EX-10.64 gdnsf-20231231xex10d64.htm EX-10.64 25206
4 EX-10.65 gdnsf-20231231xex10d65.htm EX-10.65 20234
5 EX-31.3 gdnsf-20231231xex31d3.htm EX-31.3 4518
6 EX-31.4 gdnsf-20231231xex31d4.htm EX-31.4 5300
  Complete submission text file 0001558370-24-006114.txt   1327238

Data Files

Seq Description Document Type Size
7 EX-101.SCH gdnsf-20231231.xsd EX-101.SCH 5413
8 EX-101.DEF gdnsf-20231231_def.xml EX-101.DEF 55107
9 EX-101.LAB gdnsf-20231231_lab.xml EX-101.LAB 32493
10 EX-101.PRE gdnsf-20231231_pre.xml EX-101.PRE 21731
23 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20231231x10ka_htm.xml XML 12312
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56225 | Film No.: 24890975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)